Loading...

Feig, Stephen

TitleClinical Professor
InstitutionUniversity of California, Irvine
DepartmentRadiological Sciences
Address1001 Health Sciences Road
CA 92697-3950
Phone(714) 456-6905
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Aminololama-Shakeri S, Flowers CI, McLaren CE, Wisner DJ, de Guzman J, Campbell JE, Bassett LW, Ojeda-Fournier H, Gerlach K, Hargreaves J, Elson SL, Retallack H, Joe BN, Feig S, Wells CJ. Can Radiologists Predict the Presence of Ductal Carcinoma In Situ and Invasive Breast Cancer? AJR Am J Roentgenol. 2017 Apr; 208(4):933-939. PMID: 28199152.
      View in: PubMed
    2. Lee AY, Wisner DJ, Aminololama-Shakeri S, Arasu VA, Feig S, Hargreaves J, Ojeda-Fournier H, Bassett LW, Wells CJ, De Guzman J, Flowers CI, Campbell JE, Elson SL, Retallack H, Joe BN. Inter-reader Variability in the Use of BI-RADS Descriptors for Suspicious Findings on Diagnostic Mammography: A Multi-institution Study of 10 Academic Radiologists. Acad Radiol. 2017 Jan; 24(1):60-66. PMID: 27793579.
      View in: PubMed
    3. Nayak L, Miyake KK, Leung JW, Price ER, Liu YI, Joe BN, Sickles EA, Thomas WR, Lipson JA, Daniel BL, Hargreaves J, Brenner RJ, Bassett LW, Ojeda-Fournier H, Lindfors KK, Feig S, Ikeda DM. Impact of Breast Density Legislation on Breast Cancer Risk Assessment and Supplemental Screening: A Survey of 110 Radiology Facilities. Breast J. 2016 Sep; 22(5):493-500. PMID: 27296462.
      View in: PubMed
    4. Feig S. Personalized Screening for Breast Cancer: A Wolf in Sheep's Clothing? AJR Am J Roentgenol. 2015 Dec; 205(6):1365-71. PMID: 26348933.
      View in: PubMed
    5. Morris E, Feig S, Drexler M, Lehman C. Implications of Overdiagnosis: Impact on Screening Mammography Practices. Popul Health Manag. 2015 Sep; 18 Suppl 1:S3-11. PMID: 26414384; PMCID: PMC4589101.
    6. Molloi S, Ding H, Feig S. Breast density evaluation using spectral mammography, radiologist reader assessment, and segmentation techniques: a retrospective study based on left and right breast comparison. Acad Radiol. 2015 Aug; 22(8):1052-9. PMID: 26031229; PMCID: PMC4515382.
    7. Miglioretti DL, Ichikawa L, Smith RA, Bassett LW, Feig S, Monsees B, Parikh JR, Rosenberg RD, Sickles EA, Carney PA. Criteria for identifying radiologists with acceptable screening mammography interpretive performance on basis of multiple performance measures. AJR Am J Roentgenol. 2015 Apr; 204(4):W486-91. PMID: 25794100; PMCID: PMC4369798.
    8. Feig S. Overdiagnosis of breast cancer at screening is clinically insignificant. Acad Radiol. 2015 Aug; 22(8):961-6. PMID: 25797300.
      View in: PubMed
    9. Molloi S, Ducote JL, Ding H, Feig S. Postmortem validation of breast density using dual-energy mammography. Med Phys. 2014 Aug; 41(8):081917. PMID: 25086548; PMCID: PMC4119195.
    10. Feig S. Invited commentary: digital breast tomosynthesis-the road ahead. Radiographics. 2014 Jul-Aug; 34(4):E103-5. PMID: 25019449.
      View in: PubMed
    11. Feig S. Screening mammography benefit controversies: sorting the evidence. Radiol Clin North Am. 2014 May; 52(3):455-80. PMID: 24792649.
      View in: PubMed
    12. Price ER, Hargreaves J, Lipson JA, Sickles EA, Brenner RJ, Lindfors KK, Joe BN, Leung JW, Feig S, Bassett LW, Ojeda-Fournier H, Daniel BL, Kurian AW, Love E, Ryan L, Walgenbach DD, Ikeda DM. The California breast density information group: a collaborative response to the issues of breast density, breast cancer risk, and breast density notification legislation. Radiology. 2013 Dec; 269(3):887-92. PMID: 24023072.
      View in: PubMed
    13. Carney PA, Parikh J, Sickles EA, Feig S, Monsees B, Bassett LW, Smith RA, Rosenberg R, Ichikawa L, Wallace J, Tran K, Miglioretti DL. Diagnostic mammography: identifying minimally acceptable interpretive performance criteria. Radiology. 2013 May; 267(2):359-67. PMID: 23297329; PMCID: PMC3632803.
    14. Feig S. Reply: To PMID 22528916. AJR Am J Roentgenol. 2013 Jan; 200(1):W98-9. PMID: 23379023.
      View in: PubMed
    15. Carney PA, Abraham L, Cook A, Feig S, Sickles EA, Miglioretti DL, Geller BM, Yankaskas BC, Elmore JG. Impact of an educational intervention designed to reduce unnecessary recall during screening mammography. Acad Radiol. 2012 Sep; 19(9):1114-20. PMID: 22727623.
      View in: PubMed
    16. Feig S. Number needed to screen: appropriate use of this new basis for screening mammography guidelines. AJR Am J Roentgenol. 2012 May; 198(5):1214-7. PMID: 22528916.
      View in: PubMed
    17. Kuzucan A, Chen JH, Bahri S, Mehta RS, Carpenter PM, Fwu PT, Yu HJ, Hsiang DJ, Lane KT, Butler JA, Feig S, Su MY. Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile. Clin Breast Cancer. 2012 Apr; 12(2):110-8. PMID: 22444717; PMCID: PMC3342312.
    18. Carney PA, Cook AJ, Miglioretti DL, Feig S, Bowles EA, Geller BM, Kerlikowske K, Kettler M, Onega T, Elmore JG. Use of clinical history affects accuracy of interpretive performance of screening mammography. J Clin Epidemiol. 2012 Feb; 65(2):219-30. PMID: 22000816; PMCID: PMC3253253.
    19. Chen JH, Bahri S, Mehta RS, Kuzucan A, Yu HJ, Carpenter PM, Feig S, Lin M, Hsiang DJ, Lane KT, Butler JA, Nalcioglu O, Su MY. Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging. Radiology. 2011 Dec; 261(3):735-43. PMID: 21878615; PMCID: PMC3219909.
    20. Feig S. Comparison of costs and benefits of breast cancer screening with mammography, ultrasonography, and MRI. Obstet Gynecol Clin North Am. 2011 Mar; 38(1):179-96, ix. PMID: 21419333.
      View in: PubMed
    21. Carney PA, Bowles EJ, Sickles EA, Geller BM, Feig S, Jackson S, Brown D, Cook A, Yankaskas BC, Miglioretti DL, Elmore JG. Using a tailored web-based intervention to set goals to reduce unnecessary recall. Acad Radiol. 2011 Apr; 18(4):495-503. PMID: 21251856; PMCID: PMC3065970.
    22. Carney PA, Geller BM, Sickles EA, Miglioretti DL, Aiello Bowles EJ, Abraham L, Feig S, Brown D, Cook AJ, Yankaskas BC, Elmore JG. Feasibility and satisfaction with a tailored web-based audit intervention for recalibrating radiologists' thresholds for conducting additional work-up. Acad Radiol. 2011 Mar; 18(3):369-76. PMID: 21193335; PMCID: PMC3034778.
    23. Feig S. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening. Radiol Clin North Am. 2010 Sep; 48(5):879-91. PMID: 20868891.
      View in: PubMed
    24. Lebovic GS, Hollingsworth A, Feig S. Risk assessment, screening and prevention of breast cancer: A look at cost-effectiveness. Breast. 2010 Aug; 19(4):260-7. PMID: 20399656.
      View in: PubMed
    25. Carney PA, Sickles EA, Monsees BS, Bassett LW, Brenner RJ, Feig S, Smith RA, Rosenberg RD, Bogart TA, Browning S, Barry JW, Kelly MM, Tran KA, Miglioretti DL. Identifying minimally acceptable interpretive performance criteria for screening mammography. Radiology. 2010 May; 255(2):354-61. PMID: 20413750; PMCID: PMC2858814.
    26. Lee CH, Dershaw DD, Kopans D, Evans P, Monsees B, Monticciolo D, Brenner RJ, Bassett L, Berg W, Feig S, Hendrick E, Mendelson E, D'Orsi C, Sickles E, Burhenne LW. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol. 2010 Jan; 7(1):18-27. PMID: 20129267.
      View in: PubMed
    27. Molloi S, Mehraien T, Iribarren C, Smith C, Ducote JL, Feig S. Reproducibility of breast arterial calcium mass quantification using digital mammography. Acad Radiol. 2009 Mar; 16(3):275-82. PMID: 19201356; PMCID: PMC2664654.
    28. Simpson WL, Hermann G, Rausch DR, Sherman J, Feig S, Bleiweiss IJ, Jaffer S, Port A. Ultrasound detection of nonpalpable mammographically occult malignancy. Can Assoc Radiol J. 2008 Apr; 59(2):70-6. PMID: 18533395.
      View in: PubMed
    29. Feig S. Auditing and benchmarks in screening and diagnostic mammography. Radiol Clin North Am. 2007 Sep; 45(5):791-800, vi. PMID: 17888769.
      View in: PubMed
    30. Feig S. Screening mammography: a successful public health initiative. Rev Panam Salud Publica. 2006 Aug-Sep; 20(2-3):125-33. PMID: 17199907.
      View in: PubMed
    31. Feig S. Screening mammography controversies: resolved, partly resolved, and unresolved. Breast J. 2005 Mar-Apr; 11 Suppl 1:S3-6. PMID: 15725113.
      View in: PubMed
    32. Feig S. Adverse effects of screening mammography. Radiol Clin North Am. 2004 Sep; 42(5):807-19, v. PMID: 15337417.
      View in: PubMed
    33. Feig S, Sickles EA, Evans WP, Linver MN. Re: Changes in breast cancer detection and mammography recall rates after the introduction of a computer-aided detection system. J Natl Cancer Inst. 2004 Aug 18; 96(16):1260-1; author reply 1261. PMID: 15316065.
      View in: PubMed
    34. Kopans DB, Monsees B, Feig S. Screening for cancer: when is it valid?--Lessons from the mammography experience. Radiology. 2003 Nov; 229(2):319-27. PMID: 14595137.
      View in: PubMed
    35. Bassett LW, Monsees BS, Smith RA, Wang L, Hooshi P, Farria DM, Sayre JW, Feig S, Jackson VP. Survey of radiology residents: breast imaging training and attitudes. Radiology. 2003 Jun; 227(3):862-9. PMID: 12728182.
      View in: PubMed
    36. Feig S. How reliable is the evidence for screening mammography? Recent Results Cancer Res. 2003; 163:129-39; discussion 264-6. PMID: 12903849.
      View in: PubMed
    37. Feig S. Effect of service screening mammography on population mortality from breast carcinoma. Cancer. 2002 Aug 01; 95(3):451-7. PMID: 12209736.
      View in: PubMed
    38. Feig S. Image quality of screening mammography: effect on clinical outcome. AJR Am J Roentgenol. 2002 Apr; 178(4):805-7. PMID: 11906850.
      View in: PubMed
    39. Schwartz GF, Feig S. Nonpalpable breast lesions: biopsy methods and patient management. Obstet Gynecol Clin North Am. 2002 Mar; 29(1):137-57. PMID: 11892863.
      View in: PubMed
    40. Feig S. Current status of screening mammography. Obstet Gynecol Clin North Am. 2002 Mar; 29(1):123-36. PMID: 11892862.
      View in: PubMed
    41. Kopans DB, Monsees B, Smith R, Feig S. Ten criteria for effective screening. AJR Am J Roentgenol. 2002 Feb; 178(2):508-10. PMID: 11804929.
      View in: PubMed